Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 1;70(2):131-143.
doi: 10.1097/MAT.0000000000002128. Epub 2024 Jan 5.

Extracorporeal Life Support Organization Registry International Report 2022: 100,000 Survivors

Collaborators, Affiliations

Extracorporeal Life Support Organization Registry International Report 2022: 100,000 Survivors

Joseph E Tonna et al. ASAIO J. .

Abstract

The Extracorporeal Life Support Organization (ELSO) maintains the world's largest extracorporeal membrane oxygenation (ECMO) registry by volume, center participation, and international scope. This 2022 ELSO Registry Report describes the program characteristics of ECMO centers, processes of ECMO care, and reported outcomes. Neonates (0-28 days), children (29 days-17 years), and adults (≥18 years) supported with ECMO from 2009 through 2022 and reported to the ELSO Registry were included. This report describes adjunctive therapies, support modes, treatments, complications, and survival outcomes. Data are presented descriptively as counts and percent or median and interquartile range (IQR) by year, group, or level. Missing values were excluded before calculating descriptive statistics. Complications are reported per 1,000 ECMO hours. From 2009 to 2022, 154,568 ECMO runs were entered into the ELSO Registry. Seven hundred and eighty centers submitted data during this time (557 in 2022). Since 2009, the median annual number of adult ECMO runs per center per year increased from 4 to 15, whereas for pediatric and neonatal runs, the rate decreased from 12 to 7. Over 50% of patients were transferred to the reporting ECMO center; 20% of these patients were transported with ECMO. The use of prone positioning before respiratory ECMO increased from 15% (2019) to 44% (2021) for adults during the coronavirus disease-2019 (COVID-19) pandemic. Survival to hospital discharge was greatest at 68.5% for neonatal respiratory support and lowest at 29.5% for ECPR delivered to adults. By 2022, the Registry had enrolled its 200,000th ECMO patient and 100,000th patient discharged alive. Since its inception, the ELSO Registry has helped centers measure and compare outcomes across its member centers and strategies of care. Continued growth and development of the Registry will aim to bolster its utility to patients and centers.

PubMed Disclaimer

Conflict of interest statement

Disclosure: J.E.T. is the Chair of the Registry Committee of the Extracorporeal Life Support Organization (ELSO). P.S.B. receives salary support from ELSO. G.M. is the President of ELSO. M.P. is the Immediate past President of ELSO. D.B. receives research support from and consults for LivaNova. He has been on the medical advisory boards for Abiomed, Xenios, Medtronic, Inspira, and Cellenkos. He is the President-elect of ELSO and the Chair of the Executive Committee of the International ECMO Network (ECMONet), and he writes for UpToDate. M.A., A.H., and K.R. are the Immediate Past Co-Chairs of the Scientific Oversight Committee of ELSO. P.R. is the Executive Director of ELSO. C.S. is the Chief Executive Officer (CEO) of ELSO. N.A.B. is the President of European Chapter of ELSO. N.A.B. has been on the medical advisory boards for Xenios and Baxter. T.M. is on the Board of Directors of ELSO. R.D.G. is the President of the Latin-American Chapter of ELSO. P.M.K. is the President of the South West Asia and Africa Chapter of ELSO. J.F.F. is the President of Asia-Pacific Chapter of ELSO. P.M.A.A. is Treasurer of ELSO Board of Directors. P.M.A.A. is funded by U.S. DoD PRMRP Clinical Trial Award #W81XWH2210301, NIH (R13HD104432) and FDA UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation (U01FD004979/U01FD005978). None of the funding sources were involved in the design or conduct of the study, collection, management, analysis, or interpretation of the data, or preparation, review, or approval of the manuscript. No other conflicts of interest reported. R.P.B. is a member of the Board of Directors for ELSO and receives funding from the National Heart, Lung, And Blood Institute (R01 HL153519).

Figures

Figure 1.
Figure 1.
Timeline of the Extracorporeal Life Support Organization registry data collection highlights and addenda. New data elements have been added to the main registry and with addenda. These newer data elements include dates and times of procedures and complications, level of mobilization during ECMO, the use of prone positioning before ECMO, and ICU type. Mobilization on ECMO was defined as score of >0 on the ICU mobility scale (IMS), which indicates active or active assisted exercise, such as rolling, bridging or cycle ergometry, or greater. A score of 0 is passive activity/movement. The cardiac addendum contains additional diagnostic, procedural, and echocardiographic data, as well as indications for support, postoperative and cardiac function. Version 1 was designed for neonates and children, a revised cardiac addendum (Version 2) appropriate for adults, will be released in 2023. The ECPR addendum (Version 1) began in 2005 and was revised in January 2020 (Version 2) and now contains precipitating and antecedent events, comorbid conditions, arrest and cannulation location, subsequent intra-arrest management, initial arrest rhythms, details on post arrest clinical management, and neurologic outcomes. ELSO began collecting data specific to the ECMO care of patients with SARS-CoV-2 in early 2020.- Dates and times of procedures and complications were added September 15, 2016. Lactate (worst value) was added January 1, 2017, and then transitioned to pre-ECMO value (as defined for other pre-ECMO variables) January 15, 2018. SpO2 was added January 15, 2017. Prone positioning was added December 1, 2017. Mobilization and enteral feeding data were added January 15, 2018.
Figure 2.
Figure 2.
Runs over time by age group. Y2-axis shows the number of runs over time by age group (colors), using data from 2009 to 2022 (inclusive). Run counts are indicated in the figure for color (age group) for the first and last years of the chart for reference. Y1-axis shows the number of centers (orange line with box counts in 2009 and 2022). Run counts in 2009 for adult age group: 850. Run counts in 2021: neonatal: 1,527; pediatric: 2,394; adult: 17,975.
Figure 3.
Figure 3.
Run count by region over time. Number of runs over time by ELSO chapter (colors), using data from 2009 to 2022 (inclusive). Boxed numbers indicate runs counts for years 2009 and 2022 for visual reference according to color (ELSO Chapter). Run counts in 2009: North American: 2,300; European: 529; Asia-Pacific: 381; Latin American: 45; South and West Asian: 7. Run counts in 2021: North American: 15,430; European: 3,390; Asia-Pacific: 1,542; Latin American: 707; South and West Asian: 827. Run counts in 2022: North American: 12,587; European: 2,248; Asia-Pacific: 959; Latin American: 470; South and West Asian: 539. Center counts in 2009: North American: 124; European: 24; Asia-Pacific: 13; Latin American: 4; South and West Asian: 1. Center counts in 2021: North American: 350; European: 108; Asia-Pacific: 57; Latin American: 45; South and West Asian: 31. Center counts in 2022: North American: 352; European: 107; Asia-Pacific: 43; Latin American: 32; South and West Asian: 31.
Figure 4.
Figure 4.
Center-level volume over time, log scale. Distribution of annual center-level volume (log2-scale) over time by age group (colors). Boxes cover the middle 50% and whiskers cover the middle 80%. Center volume for neonatal/pediatric centers: 2009: median 12, interquartile range (IQR) 6, 23; 2021: 8 (2, 18.5); 2022: 7 (2, 17); Center volume for adult centers: 2009: 4 (1, 12); 2021: 20 (7, 48); 2022: 15 (6, 36).
Figure 5.
Figure 5.
Distribution of COVID-19 status in adult receiving respiratory support ECMO in 2020 through 2022. COVID-19 test status is indicated by colors for each of three years. Bar height represents proportion from 0 to 1, shown on the Y-axes.
Figure 6.
Figure 6.
Runs over time by age group and support type. Number of runs over time by support type (colors) and age group (panels), from 2009 to 2022 (inclusive). Boxed numbers indicate runs counts for years 2009 and 2022 for visual reference according to color (support type). Run counts: neonatal ECPR (2009): 112; neonatal ECPR (2021): 175; neonatal Cardiac (2021): 589; neonatal Respiratory (2021): 763: neonatal ECPR (2022): 168; pediatric ECPR (2009): 219; pediatric ECPR (2021): 501; pediatric Cardiac (2021): 1,162; pediatric Respiratory; adult ECPR (2009): 86; adult Cardiac (2009): 269; adult Respiratory (2009): 495; adult ECPR (2022): 2,069.
Figure 7.
Figure 7.
Proportion of prone positioning use before respiratory support ECMO by age group from 2019 through 2022. Age groups are indicated by colors for each of three years. Bar height represents proportion from 0 to 1, shown on the Y-axes.

Comment in

  • ELSO Registry Reports: A New Look.
    Zwischenberger JB. Zwischenberger JB. ASAIO J. 2024 Feb 1;70(2):144-145. doi: 10.1097/MAT.0000000000002145. Epub 2024 Jan 26. ASAIO J. 2024. PMID: 38289567 No abstract available.

References

    1. Toomasian JM, Snedecor SM, Cornell RG, Cilley RE, Bartlett RH: National experience with extracorporeal membrane oxygenation for newborn respiratory failure Data from 715 cases. ASAIO Trans 34: 140–147, 1988. - PubMed
    1. Tonna JE, Barbaro RP, Rycus PT, et al.: On the academic value of 30 years of the extracorporeal life support organization registry. ASAIO J 67: 1–3, 2021. - PMC - PubMed
    1. Stolar CJ, Delosh T, Bartlett RH: Extracorporeal life support organization 1993. ASAIO J 39: 976–979, 1993. - PubMed
    1. UK Collaborative Randomised Trial of Neonatal Extracorporeal Membrane Oxygenation: UK Collaborative ECMO Trail Group. Lancet 348: 75–82, 1996. - PubMed
    1. Mugford M, Elbourne D, Field D: Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. Cochrane Database Syst Rev (3): CD001340, 2008. - PubMed

Publication types